A Co Cavan veterinary medicines supplier has taken a High Court case challenging the decision to grant import licences allowing a Czech pharmaceutical manufacturer to sell its bovine mastitis treatments in Ireland.
In a sworn statement, Univet’s company director, George Crowe, claims the Minister has “abused his power” by allegedly issuing a series of SILs for Gamaret “virtually on demand”, with the first allegedly granted in late October 2020. He claims that there were seven products available in Ireland for treating mastitis in lactating cows prior to January 2020. He said this includes Terrexine, which is manufactured by his own company. All seven products in circulation were authorised for sale in this State by the HPRA, he added.
Mr Crowe said this decision, and the subsequent issuing of further licences, was “without legal foundation” as he claimed there was no health situation requiring the immediate importation and there was no shortage of supply of the animal remedy.He claims the withdrawal of Tetra-Delta did not cause a shortage and any potential shortfall would have been made up “without delay or difficulty” by the existing suppliers.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kerry Group launches €6m dairy sustainability programmeFood technology and ingredients company Kerry Group has launched a €6 million sustainability programme, designed to support milk suppliers transition to more sustainable farming practices.
Source: RTEbusiness - 🏆 16. / 61 Read more »
Source: IrishTimesBiz - 🏆 6. / 77 Read more »